Cite
MLA Citation
Benjamin A Fisher et al.. “Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.” Lancet, vol. 2, 2020, pp. e142–e152. http://access.bl.uk/ark:/81055/vdc_100101666096.0x000001